ELVN vs ADMA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ADMA Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ADMA Biologics, Inc. (ADMA) driven by superior Valuation, Growth & Margin, Options & Structure while ELVN counters with relative strength in Momentum & Technical. Fundamentally, ELVN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ADMA at 15.7x Forward P/E and 44.9% operating margin (+5.1% YoY). In options structure, ELVN sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro) against ADMA sits in SURGE (8th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ELVN | ADMA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.6B | $2.9B | Larger Scale | ELVN |
| Trailing P/E Ratio Valuation | N/M | 17.2x | Lower Multiple | ADMA |
| Forward P/E Ratio Valuation | N/M | 15.7x | Lower Multiple | ADMA |
| Revenue Growth (YoY) Growth | +0.0% | +5.1% | Higher Growth | ADMA |
| Operating Margin (TTM) Profitability | 0.0% | 44.9% | Higher Margin | ADMA |
| Net Profit Margin Profitability | 0.0% | 35.1% | Higher Margin | ADMA |
| Return on Equity (ROE) Capital Efficiency | -16.8% | 41.9% | Higher ROE | ADMA |
| 52-Week Range Position Momentum | 69% ($15โ$62) | 49% ($7โ$20) | Stronger Trend | ELVN |
| Beta / 30D Volatility Risk Regime | 0.96ฮฒ ยท 60% Vol | -0.42ฮฒ ยท 99% Vol | Lower Realized Risk | ELVN |
| Unified Institutional Score Composite Signal | 35.9 / 100 (SELL) | 26.5 / 100 (SELL) | Higher Composite | ELVN |